Prevention and Treatment of Tobacco Use,Journal of the American College of Cardiology

当前位置： X-MOL 学术 › J. Am. Coll. Cardiol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Prevention and Treatment of Tobacco Use
Journal of the American College of Cardiology ( IF 21.7 ) Pub Date : 2018-08-01 , DOI: 10.1016/j.jacc.2018.06.036
Sara Kalkhoran ₁ , Neal L Benowitz ₂ , Nancy A Rigotti ₁

Affiliation

Tobacco use is the leading preventable cause of death worldwide and is a major risk factor for cardiovascular disease (CVD). Both prevention of smoking initiation among youth and smoking cessation among established smokers are key for reducing smoking prevalence and the associated negative health consequences. Proven tobacco cessation treatment includes pharmacotherapy and behavioral support, which are most effective when provided together. First-line medications (varenicline, bupropion, and nicotine replacement) are effective and safe for patients with CVD. Clinicians who care for patients with CVD should give as high a priority to treating tobacco use as to managing other CVD risk factors. Broader tobacco control efforts to raise tobacco taxes, adopt smoke-free laws, conduct mass media campaigns, and restrict tobacco marketing enhance clinicians' actions working with individual smokers.

中文翻译：

烟草使用的预防和治疗

烟草使用是全球主要的可预防死亡原因，也是心血管疾病 (CVD) 的主要危险因素。预防青少年开始吸烟和吸烟者戒烟都是减少吸烟率和相关负面健康后果的关键。经证实的戒烟治疗包括药物治疗和行为支持，两者结合使用时最有效。一线药物（伐尼克兰、安非他酮和尼古丁替代品）对 CVD 患者有效且安全。护理 CVD 患者的临床医生应像管理其他 CVD 危险因素一样高度重视治疗烟草使用。提高烟草税、通过无烟法、开展大众媒体宣传活动和限制烟草营销等更广泛的烟草控制努力，加强了临床医生与个体吸烟者合作的行动。

更新日期：2018-08-01

点击分享查看原文

点击收藏

公开下载

阅读更多本刊新发论文本刊介绍/投稿指南